StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
United Therapeutics Corp. (UTHR) PT Raised to $733 at Jefferies
March 30, 2026 10:26 AM
Jefferies analyst Roger Song raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $733.00 (from $668.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
United Therapeutics Corp. (UTHR) PT Raised to $660 at TD Cowen, 'remains a top pick'
March 30, 2026 8:33 AM
Morgan Stanley on United Therapeutics Corp. (UTHR): project Tyvaso '2030/2035 risk-adjusted sales in IPF of $1.2bn/$2.5bn'
March 30, 2026 8:18 AM
Jefferies on United Therapeutics Corp. (UTHR): expecting '+15–25%' move following positive topline data
March 30, 2026 8:11 AM
Form 8-K UNITED THERAPEUTICS Corp For: Mar 30
March 30, 2026 7:01 AM
